E Yarkoni
- Biotechnology top 5%
- Cancer Research and Treatments 11
- Immunology top 10%
- Immunotherapy and Immune Responses 13
- Immune Response and Inflammation 6
- Immune Cell Function and Interaction 5
- Microbiology top 10%
- Infectious Diseases top 10%
- Microbiology top 10%
-
- Cancer Cells and Metastasis 8
-
- Mycobacterium research and diagnosis 6
-
- Virus-based gene therapy research 4
-
- Neonatal Respiratory Health Research 3
- Co-authors
- A. BekierkunstH. J. RappE. LedererE. VilkasI.S. LevijHerbert J. RappA. AdamMonte S. Meltzer
- Cited by
- BiotechnologyImmunologyMicrobiology
- Journals
- Infection and Immunity (20 papers)Cancer Immunology Immunotherapy (5 papers)International Journal of Cancer (2 papers)
- Partner nations
- United StatesFranceIsrael
In The Last Decade
E Yarkoni
40 papers receiving 658 citations
Peers
Comparison fields: 5 of 77
- Biotechnology 130
- Immunology 313
- Microbiology 8
- Infectious Diseases 192
- Microbiology 53
Countries citing papers authored by E Yarkoni
This map shows the geographic impact of E Yarkoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Yarkoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Yarkoni more than expected).
Fields of papers citing papers by E Yarkoni
This network shows the impact of papers produced by E Yarkoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Yarkoni. The network helps show where E Yarkoni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E Yarkoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 4 | |
| 2 | 1981 | 3 | |
| 3 | 1981 | 37 | |
| 4 | 1980 | 10 | |
| 5 | Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria. | 1979 | 16 |
| 6 | 1979 | 2 | |
| 7 | 1979 | 2 | |
| 8 | 1979 | 4 | |
| 9 | 1979 | 4 | |
| 10 | 1979 | 7 | |
| 11 | 1978 | 9 | |
| 12 | 1978 | 2 | |
| 13 | 1978 | 23 | |
| 14 | 1977 | 16 | |
| 15 | 1976 | 45 | |
| 16 | 1976 | 9 | |
| 17 | 1973 | 27 | |
| 18 | Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor). | 1973 | 21 |
| 19 | 1971 | 37 | |
| 20 | 1971 | 87 |
About E Yarkoni
E Yarkoni is a scholar working on Biotechnology, Immunology and Oncology, having authored 40 papers that have together received 860 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer Research and Treatments (11 papers), Cancer Cells and Metastasis (8 papers), Mycobacterium research and diagnosis (6 papers), Immune Response and Inflammation (6 papers), Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (4 papers) and Neonatal Respiratory Health Research (3 papers). The work is most often cited by research in Biotechnology (130 citations), Immunology (313 citations) and Microbiology (8 citations). E Yarkoni has collaborated with scholars based in United States, France and Israel. Frequent co-authors include A. Bekierkunst, H. J. Rapp, E. Lederer, E. Vilkas, I.S. Levij, Herbert J. Rapp, A. Adam, Monte S. Meltzer, I. Flechner and Shoshana Morecki. Their work appears in journals such as Infection and Immunity, Cancer Immunology Immunotherapy, International Journal of Cancer, JNCI Journal of the National Cancer Institute and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.